Improved synthesis of 4-cyanotryptophan and other tryptophan analogs in aqueous solvent using variants of TrpB from Thermotoga maritima
Abstract
The use of enzymes has become increasingly widespread in synthesis as chemists strive to reduce their reliance on organic solvents in favor of more environmentally benign aqueous media. With this in mind, we previously endeavored to engineer the tryptophan synthase β-subunit (TrpB) for production of noncanonical amino acids that had previously been synthesized through multistep routes involving water-sensitive reagents. This enzymatic platform proved effective for the synthesis of analogues of the amino acid tryptophan (Trp), which are frequently used in pharmaceutical synthesis as well as chemical biology. However, certain valuable compounds, such as the blue fluorescent amino acid 4-cyanotryptophan (4-CN-Trp), could only be made in low yield, even at elevated temperature (75 °C). Here, we describe the engineering of TrpB from Thermotoga maritima that improved synthesis of 4-CN-Trp from 24% to 78% yield. Remarkably, although the final enzyme maintains high thermostability (T50 = 93 °C), its temperature profile is shifted such that high reactivity is observed at ∼37 °C (76% yield), creating the possibility for in vivo 4-CN-Trp production. The improvements are not specific to 4-CN-Trp; a boost in activity at lower temperature is also demonstrated for other Trp analogues.
Additional Information
© 2018 American Chemical Society. Received: February 25, 2018; Published: April 13, 2018. Special Issue: Organic and Biocompatible Transformations in Aqueous Media. This work was funded by the Jacobs Institute for Molecular Engineering for Medicine (JIMEM) and the Rothenberg Innovation Initiative (RI2) at Caltech. C.E.B. was supported by a postdoctoral fellowship from the Resnick Sustainability Institute, D.K.R. was supported by a Ruth Kirschstein NIH Postdoctoral Fellowship (F32GM117635), and M.S. was supported by a postdoctoral fellowship from the German Academic Exchange Service (DAAD). The authors declare the following competing financial interest(s): The contents of this paper are the subject of a patent application submitted by Caltech, and some authors are entitled to a royalty on revenues arising from that patent. Author Contributions: C.E.B. and D.K.R. contributed equally to this work.Attached Files
Accepted Version - nihms960701.pdf
Supplemental Material - jo8b00517_si_001.pdf
Files
Name | Size | Download all |
---|---|---|
md5:ba471590c251ddd66ae817ceadde2ada
|
545.1 kB | Preview Download |
md5:9d9ceb3956b2425f8ed6024a14895f97
|
320.2 kB | Preview Download |
Additional details
- PMCID
- PMC6054569
- Eprint ID
- 85817
- Resolver ID
- CaltechAUTHORS:20180413-091558960
- Jacobs Institute for Molecular Engineering for Medicine
- Rothenberg Innovation Initiative (RI2)
- Resnick Sustainability Institute
- NIH Postdoctoral Fellowship
- F32GM117635
- Deutscher Akademischer Austauschdienst (DAAD)
- Created
-
2018-04-13Created from EPrint's datestamp field
- Updated
-
2022-03-11Created from EPrint's last_modified field
- Caltech groups
- Resnick Sustainability Institute, Jacobs Institute for Molecular Engineering for Medicine